Baculovirus Vaccine Protects Mice from H9N2 Influenza
Author Information
Author(s): Lin Wenyao, Fan Huiying, Cheng Xiaoliang, Ye Yu, Chen Xiaowei, Ren Tao, Qi Wenbao, Liao Ming
Primary Institution: South China Agricultural University
Hypothesis
Can a baculovirus dual expression system-based vaccine provide protection against H9N2 avian influenza virus in mice?
Conclusion
The BV-Dual-HA vaccine provides complete protection against lethal H9N2 virus challenge in mice.
Supporting Evidence
- Immunization with BV-Dual-HA induced the highest levels of H9-specific antibodies.
- All mice immunized with BV-Dual-HA developed detectable antibodies after vaccination.
- BV-Dual-HA provided 100% protection against lethal H9N2 virus challenge.
- Mice vaccinated with BV-Dual-HA had undetectable viral titers in their lungs after challenge.
Takeaway
Scientists created a new vaccine using a virus that helps make proteins, and it completely protected mice from getting sick from a type of bird flu.
Methodology
Mice were vaccinated with the BV-Dual-HA vaccine and then challenged with the H9N2 virus to assess protection and immune response.
Limitations
The study primarily focused on a mouse model, which may not fully represent human responses.
Participant Demographics
Six-week-old BALB/c female mice were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website